--

 
-::
-::

Product Origin

-::
-::
-::
-::
-::
-
-::

BASQÜADÉ

-::
 

BUY A TREATMENT

Ver video de presentación

 

Contact us:
info@basquade.com

Farmeco Lted.
Constituyente 1735
Phone (+598) 2403.2341
(+598) 2402.3735

Montevideo-Uruguay

 
 

Clinical cases of lung cancer

Case 1: Lung cancer with brain metastasi


Age: 48 years old

Personal history:

Nothing relevant.

Family history:

Nothing relevant.

Present illness’ history:

History of right neumonectomy because of carcinoma (24/01/2000) with treatment (chimiotherapy and radiotherapy), with good later evolution. After starts with suggestive symptoms of encephalic compromise what leads to macroscopic exams

Illness’ evolution:

06/09/2002 – Improves widely the neurological symptoms with wide reductionof pathological image at the central nervous system level. Continues stable without illness progress until nowadays. Continues with 60 drops under the tongue every 6 hours.

Conclusions:

Undoubtedly,Basquadé® has benefited the patient who has a severe illness ando f difficult treatment, avoiding convulsions (that she had) and achieving a clear improvement, either in the primitive as well as in the metastasi. Basqüadé® has a marked anti-neoplasic action in which we have a practice of many years with our medical crew. The medicine has been of enormous efficiency in this patient who has a normal life nowadays.

Case 2: Epidermoid carcinoma of lung

Age: 48 years old

Reason why consults:

Progressive dyspnoea.

Personal history:

Heavy smoker.

Family history:

Nothing relevant so as to be highlighted.

Present illness’ history:

Tomography studies. 23/07/1998. Report: a solid mass of approximately 5 cm obstructs the upper lobar bronchial.
Rest of the study without relevant elements to highlight.
Pathologic anatomy:the examined sections show a malignant epithelium proliferation with the morphology of an epidermoid carcinoma, moderately differentiated.
Illness’ evolution:

Telecobalt-theraphy is done, plus chimiotherapy.

1/09/1998: clear improvement in the imagenology.
Partial improvement.
Noviembre, 1998: starts treatment with our medicine, 30 drops 4 times a day.

Complete improvement.

Abril/2003, the patient doesn’t show any symptoms, in clinical healing, discharged from treatment in September,2000.

Conclusions:

We deal with a heavy smoker patient who carries an epidermoid lung cancer treated with convencional therapy, radiotherapy and chimiotherapy with moderately aceptable results.

He starts with our medicine later, improving clearly his general condition remaining only a very small dyspnoea but with a quick dissapearance of symptoms what makes this patient have a clinical healing. This shows Basqüadé®’s action in the lung and its metastasi.

The patient achieves a clinical healing thanks to Basqüadé® because he had been labelled as an incurable patient by the convencional medicine. The patients goes back to his city of origin and only uses Basqüadé® , achieving through this a clinical healing that we can bring into line with the clinical healings of the convencional medicine.

This shows the very powerful action of Basqüadé® on the lung parenchima, purging it from toxins and attacking the neoplasic cell in a way that surprises because of its eagerness.

Return

 



Last actualization: 25-03-2008
Powered by Zona Hosting